Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 375 entries
View as:

Health Status of the Oldest-old Population

Phase: N/A Priority: Normal
NCT ID: NCT04553874 Org: User:
Start: 12/01/20 End: 06/30/23 Due: 06/30/24

Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT02172690 Org: User:
Start: 01/01/14 End: 09/30/17 Due: 09/30/18

Mental Health Promotion Interventions Among Migrant Workers in China

Phase: N/A Priority: Normal
NCT ID: NCT02009358 Org: User:
Start: 03/31/10 End: 11/30/12 Due: 11/30/13

Effects of Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants

Phase: N/A Priority: Normal
NCT ID: NCT02880891 Org: User:
Start: 09/30/16 End: 09/30/26 Due: 09/30/27

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

Phase: N/A Priority: Normal
NCT ID: NCT04457700 Org: User:
Start: 11/01/20 End: 12/30/22 Due: 12/30/23

Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

Phase: N/A Priority: Normal
NCT ID: NCT06443307 Org: User:
Start: 07/15/24 End: 08/01/26 Due: 08/01/27

Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders

Phase: N/A Priority: Normal
NCT ID: NCT07005245 Org: User:
Start: 06/07/21 End: 11/30/22 Due: 11/30/23

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03575637 Org: User:
Start: 07/31/18 End: 06/30/21 Due: 06/30/22

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT01572324 Org: User:
Start: 03/31/12 End: 04/30/16 Due: 04/30/17

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03279601 Org: User:
Start: 09/01/17 End: 09/01/20 Due: 09/01/21

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03010579 Org: User:
Start: 10/31/16 End: 12/31/18 Due: 12/31/19

A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04616040 Org: User:
Start: 12/01/20 End: 12/01/26 Due: 12/01/27

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Phase: N/A Priority: Normal
NCT ID: NCT05165602 Org: User:
Start: 01/01/22 End: 05/01/23 Due: 05/01/24

Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05344664 Org: User:
Start: 04/14/22 End: 02/01/25 Due: 02/01/26

Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00755664 Org: User:
Start: 07/31/07 End: 09/30/12 Due: 09/30/13

Psychoeducation for the Parents of Attention Deficit Hyperactivity Disorder (ADHD) Children

Phase: N/A Priority: Normal
NCT ID: NCT02368834 Org: User:
Start: 08/31/14 End: - Due: -

Internet-Based Interventions for MDD

Phase: N/A Priority: Normal
NCT ID: NCT04684277 Org: User:
Start: 09/01/21 End: 06/30/23 Due: 06/30/24

Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT05341141 Org: User:
Start: 06/10/22 End: 11/30/26 Due: 11/30/27

Temporal Dynamics of Mindfulness Intervention for Emotional Distress: Daily Interventions and Assessments

Phase: N/A Priority: Normal
NCT ID: NCT06919406 Org: User:
Start: 04/05/25 End: 09/10/25 Due: 09/10/26

Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

Phase: N/A Priority: Normal
NCT ID: NCT04695015 Org: User:
Start: 12/31/20 End: 06/01/22 Due: 06/01/23

Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05981235 Org: User:
Start: 12/14/23 End: 11/01/28 Due: 11/01/29

Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure

Phase: N/A Priority: Normal
NCT ID: NCT03247478 Org: User:
Start: 08/25/17 End: 08/30/19 Due: 08/30/20

MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06170294 Org: User:
Start: 01/01/24 End: 12/31/28 Due: 12/31/29

Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04609176 Org: User:
Start: 11/18/20 End: 12/31/24 Due: 12/31/25

Childhood Obesity Intervention Study

Phase: N/A Priority: Normal
NCT ID: NCT03665857 Org: User:
Start: 09/11/18 End: 04/29/21 Due: 04/29/22